Bids are Invited For Acamprosate Gastro-resistant Tablets,Adapalene,Adenine,Bedaquiline fumarate,Bepotastine besilate,Ca in GHAZIABAD, UTTAR PRADESH
Bid Publish Date
07-Aug-2025, 10:51 am
Bid End Date
04-Sep-2025, 12:00 pm
EMD
₹900
Location
Progress
Indian Pharmacopoeia Commission (ipc) invites bids for Acamprosate Gastro-resistant Tablets, Adapalene, Adenine, Bedaquiline fumarate, Bepotastine besilate, Calcium Folinate Tablets, Calcium Polystyrene Sulphonate, Cefprozil, Dactinomycin or Dactinomycin for Injection, Dapagliflozin or Dapagliflozin and Metformin Hydrochloride Prolonged-release Tablets, Dapagliflozin Propanediol Monohydrate, Desloratadine or Desloratadine Tablets, Entecavir Oral Solution, Eribulin Mesylate, Eribulin Mesylate or Eribulin Injection, Etravirine or Etravirine Tablets, Fulvestrant Injection, Low-Substituted Hydroxypropyl Cellulose, Iohexol or Iohexol Injection, Micafungin Sodium, Minocycline Hydrochloride or cap or Inj or Tab, Morphine Prolonged-release Tablets, Oxytocin Concentrated Solution, Phytomenadione Tablets, Pilocarpine Hydrochloride or Pilocarpine Hydrochloride Eye drops, Pilocarpine Hydrochloride Eye drops, Pomalidomide or Cap, Proparacaine Hydrochloride or Proparacaine Eye Drops, Acamprosate impurity A, Acetylcysteine impurity A, Acetylcysteine impurity B, Acetylcysteine impurity C, Acetylcysteine impurity D, Adapalene impurity C, Adapalene impurity A, Adapalene impurity D, Bedaquiline impurity B, Bepotastine besilate R-isomer impurity, Bepotastine impurity A, Amoxycillin related compound I, Cefprozil related compound D, Celecoxib impurity A, Celecoxib impurity B, Clarithromycin identity, Clindamycin impurity E, Clindamycin impurity F, Clindamycin impurity G, Clindamycin impurity I, Clindamycin impurity J, Clindamycin impurity K, Clindamycin impurity B, Clindamycin impurity L, Ortho isomer of dapagliflozin impurity, Dapagliflozin dimer-1, Dapagliflozin impurity A, Dapagliflozin impurity B, Desloratadine related compound B, Desloratadine related compound A, Desloratadine related compound F, 5-chloro-2-methylaminobenzophenone, 3- amino-6-chloro-1-methyl-4-phenylquinolin-2-ol, Eribulin impurity C, Etravirine system suitability mixture, Frusemide related compound B, Fulvestrant Impurity A, Galantamine hydrobromide related compound mixture, Iohexol related compound B, Iohexol related compound A, Iohexol related compound C, Micafuin epimer, Minocycline impurity A, Minocycline impurity B, Minocycline impurity C, Minocycline impurity E, Minocycline impurity F, Minocycline impurity G, Minocycline impurity H, Morphine impurity F, Pilocarpine impurity A, 3-amino-4- propoxybenzoic acid in GHAZIABAD, UTTAR PRADESH. Quantity: 3640. Submission Deadline: 04-09-2025 12: 00: 00. Submit your proposal before the deadline.
Technical Results
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | AURIGA RESEARCH PRIVATE LIMITED Under PMA | - | 27-08-2025 09:25:40 | |
| 2 | Cleanchem Laboratories LLP Under PMA | - | 03-09-2025 11:10:59 | |
| 3 | CLEARSYNTH LABS LIMITED Under PMA | - | 04-09-2025 08:14:22 | |
| 4 | GLOBESYNTH PHARMA TECH Under PMA | - | 27-08-2025 23:01:43 | |
| 5 | HONEYCHEM PHARMA RESEARCH PRIVATE LIMITED Under PMA | - | 28-08-2025 10:38:46 |
Contract / Result Documents 4
Please sign in or create an account to view contract details and download result documents.
Tender Data
Bid Details
Quantity
3640
Category
Adapalene
Bid Type
Two Packet Bid
Bid Validity
180 (Days)
Bid Type
Service
Evaluation
Item wise evaluation/
Inspection Required
No
Tech Clarification Time
2 Days
Requirements
Min. Avg. Annual Turnover
38
OEM Avg. Turnover
38
Past Performance
50 %
Experience Required
3 Year (s)
Arbitration Clause
No
Mediation Clause
No
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Acamprosate Gastro-resistant Tablets , Adapalene , Adenine , Bedaquiline fumarate , Bepotastine besilate , Calcium Folinate Tablets , Calcium Polystyrene Sulphonate , Cefprozil , Dactinomycin or Dactinomycin for Injection , Dapagliflozin or Dapagliflozin and Metformin Hydrochloride Prolonged-release Tablets , Dapagliflozin Propanediol Monohydrate , Desloratadine or Desloratadine Tablets , Entecavir Oral Solution , Eribulin Mesylate , Eribulin Mesylate or Eribulin Injection , Etravirine or Etravirine Tablets , Fulvestrant Injection , Low-Substituted Hydroxypropyl Cellulose , Iohexol or Iohexol Injection , Micafungin Sodium , Minocycline Hydrochloride or cap or Inj or Tab , Morphine Prolonged-release Tablets , Oxytocin Concentrated Solution , Phytomenadione Tablets , Pilocarpine Hydrochloride or Pilocarpine Hydrochloride Eye drops , Pilocarpine Hydrochloride Eye drops , Pomalidomide or Cap , Proparacaine Hydrochloride or Proparacaine Eye Drops , Acamprosate impurity A , Acetylcysteine impurity A , Acetylcysteine impurity B , Acetylcysteine impurity C , Acetylcysteine impurity D , Adapalene impurity C , Adapalene impurity A , Adapalene impurity D , Bedaquiline impurity B , Bepotastine besilate R-isomer impurity , Bepotastine impurity A , Amoxycillin related compound I , Cefprozil related compound D , Celecoxib impurity A , Celecoxib impurity B , Clarithromycin identity , Clindamycin impurity E , Clindamycin impurity F , Clindamycin impurity G , Clindamycin impurity I , Clindamycin impurity J , Clindamycin impurity K , Clindamycin impurity B , Clindamycin impurity L , Ortho isomer of dapagliflozin impurity , Dapagliflozin dimer-1 , Dapagliflozin impurity A , Dapagliflozin impurity B , Desloratadine related compound B , Desloratadine related compound A , Desloratadine related compound F , 5-chloro-2-methylaminobenzophenone , 3- amino-6-chloro-1-methyl-4-phenylquinolin-2-ol , Eribulin impurity C , Etravirine system suitability mixture , Frusemide related compound B , Fulvestrant Impurity A , Galantamine hydrobromide related compound mixture , Iohexol related compound B , Iohexol related compound A , Iohexol related compound C , Micafuin epimer , Minocycline impurity A , Minocycline impurity B , Minocycline impurity C , Minocycline impurity E , Minocycline impurity F , Minocycline impurity G , Minocycline impurity H , Morphine impurity F , Pilocarpine impurity A , 3-amino-4- propoxybenzoic acid
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 5
GeM-Bidding-8193172.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
Other Documents
OTHER
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
85 Items Sign in to view GEM price trends Sign in for GEM prices
Acamprosate Gastro-resistant Tablets
Acamprosate calcium
Adapalene
Adapalene
Adenine
Adenine
Bedaquiline fumarate
Bedaquiline fumarate
Bepotastine besilate
Bepotastine besilate
Calcium Folinate Tablets
Calcium folinate
Calcium Polystyrene Sulphonate
Calcium polystyrene sulphonate
Cefprozil
Cefprozil Z isomer
Cefprozil
Cefprozil E isomer
Dactinomycin or Dactinomycin for Injection
Dactinomycin
Dapagliflozin or Dapagliflozin and Metformin Hydrochloride Prolonged-release Tablets
Dapagliflozin
Dapagliflozin Propanediol Monohydrate
Dapagliflozin propanediol monohydrate
Desloratadine or Desloratadine Tablets
Desloratadine
Entecavir Oral Solution
Entecavir monohydrate
Eribulin Mesylate
Methanesulphonic acid
Eribulin Mesylate or Eribulin Injection
Eribulin mesilate
Etravirine or Etravirine Tablets
Etravirine
Fulvestrant Injection
Fulvestrant
Low-Substituted Hydroxypropyl Cellulose
Low- substituted hydroxypropyl cellulose
Iohexol or Iohexol Injection
Iohexol
Micafungin Sodium
Micafungin sodium
Minocycline Hydrochloride or cap or Inj or Tab
Minocycline hydrochloride
Morphine Prolonged-release Tablets
Morphine sulphate
Morphine Prolonged-release Tablets
Codeine phosphate
Oxytocin Concentrated Solution
Oxytocin
Oxytocin Concentrated Solution
Desmopressin
Phytomenadione Tablets
Phytomenadione
Pilocarpine Hydrochloride or Pilocarpine Hydrochloride Eye drops
Pilocarpine hydrochloride
Pilocarpine Hydrochloride Eye drops
Pilocarpine nitrate
Pomalidomide or Cap
Pomalidomide
Proparacaine Hydrochloride or Proparacaine Eye Drops
Proparacaine hydrochloride
Acamprosate impurity A
3-Amino-1-propanesulphonic acid
Acetylcysteine impurity A
3, 3-disulphanediylbis (2R)-2-aminopropanoic acid (L-cystine)
Acetylcysteine impurity B
2(2R)-2-amino-3-sulphanylpropanoic acid (L-cysteine)
Acetylcysteine impurity C
33,3-disulphanediylbis(2R)-2-acetamidopropanoic acid (N, N-diacetyl-L cystine)
Acetylcysteine impurity D
(2R)-2-acetamido-3-(acetylsulphanyl)propanoic acid (N,S-diacetyl-L cysteine)
Adapalene impurity C
(1-(2-methoxyphenyl)tricyclo 3.3.1.13,7 decane)
Adapalene impurity A
(2,2-binaphthalene-6,6-dicarboxylic acid)
Adapalene impurity D
(1,1-4,4-bis(methoxy)biphenyl-3,3 Diyl bis (tricyclo 3.3.1.13,7 decane))
Bedaquiline impurity B
(1S,2R)-1-(6-bromo-2-methoxy-3quinolinyl)-4-(dimethylamino)-2-(3benzo b thiophenyl)-1-pheny-2-butanol.
Bepotastine besilate R-isomer impurity
(R)-4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid--benzenesulfonic acid
Bepotastine impurity A
((S)-4-((4-chlorophenyl)-2 (pyredylmethoxy piperidine) in the solvent mixture
Amoxycillin related compound I
(R)-2-Amino-2-(4-hydroxyphenyl) acetic acid
Cefprozil related compound D
(6R,7R)-7-Amino-8- oxo-3-(Z)-prop-1-enyl-5-thia-1-azabicyclo 4.2.0 oct-2-ene-2-carboxylic acid,
Celecoxib impurity A
(4- 5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl benzenesulphonamide)
Celecoxib impurity B
(4- 3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl benzenesulphonamide)
Clarithromycin identity
clarithromycin + clarithromycin impurity D (3-N-demethyl-6-O-methylerythromycin A)
Clindamycin impurity E
(methyl 7-chloro-6,7,8-trideoxy-6- (2S,4R)-1-methyl-4-propylpyrrolidin 2-yl carbonyl amino -1-thio-L-threo-D-galacto-octopyranoside (clindamycin).
Clindamycin impurity F
(methyl 6,8-dideoxy 6- (2S,4R)-1-methyl-4-propylpyrrolidin-2-yl carbonyl amino -2-O-phosphono-1-thio-D-erythro-D-galacto octopyranoside (lincomycin 2-phosphate))
Clindamycin impurity G
(methyl 6,8-dideoxy-2,4-O-(hydroxyphosphoryl)-6- (2S,4R)-1-methyl-4 propylpyrrolidin-2-yl carbonyl amino -1-thio-D-erythro-D-galacto octopyranoside (2,4-phosphatidyl lincomycin))
Clindamycin impurity I
methyl 7-chloro-6,7,8-trideoxy-6- (2S,4R)-1-methyl-propylpyrrolidin 2-yl carbonyl amino -2,4-di-O-phosphono-1-thio-L-threo--D-galacto octopyranoside (clindamycin 2,4-bisphosphate))
Clindamycin impurity J
(methyl 7-chloro-6,7,8-trideoxy-6- (2S)-1-methyl-4 propylidenepyrrolidin-2-yl carbonyl amino -2-O-phosphono-1-thio-L threo--D-galacto-octopyranoside (propylidene analog of clindamycin 2-phosphate))
Clindamycin impurity K
2,2-oxybis(hydroxyphosphoryl)bis methyl 7-chloro-6,7,8-trideoxy-6- (2S,4R)-1-methyl-4-propylpyrrolidin-2-yl carbonyl amino -1-thio-L- threo--D-galacto-octopyranoside (diclindamycin pyrophosphate).
Clindamycin impurity B
methyl 7-chloro-6,7,8-trideoxy-6- (2S,4R)-4-ethyl-1-methylpyrrolidin-2-yl carbonyl amino -2-O-phosphono-1-thio-L-threo--D-galacto- octopyranoside (clindamycin B 2-phosphate).
Clindamycin impurity L
(methyl 7-chloro-6,7,8-trideoxy-6- (2S,4R)-1-methyl-propylpyrrolidin 2-yl carbonyl amino -2-O-phosphono-1-thio-D-erythro--D-galacto octopyranoside (7-epiclindamycin 2-phosphate)
Ortho isomer of dapagliflozin impurity
(1S)-1,5-anhydro-1-C-(4-chloro-3- (2-ethoxyphenyl)methyl phenyl)-D-glucitol
Dapagliflozin dimer-1
(2S,3R,4R,5S,6R)-2- 4-chloro-3- (5-(2-Chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl benzyl -2-ethoxyphenyl)(4-ethoxyphenyl)methyl phenyl -6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
Dapagliflozin impurity A
((1S)-1,5-anhydro-1 4-bromo-3- (4-ethoxyphenyl)methyl phenyl -D glucitol)
Dapagliflozin impurity B
((1S)-1,5-anhydro-1 4-chloro-3- (4-ethoxy-3-ethylphenyl) methyl phenyl D-glucitol.)
Desloratadine related compound B
8-Chloro-11-(1,2,3,6-tetrahydropyridin-4-yl)-6,11-dihydro-5H-benzo 5,6 cyclohepta 1,2-b pyridine hydrochloride.
Desloratadine related compound A
8-Bromo-6,11-dihydro-11-(piperidin-4-ylidene)-5H-benzo 5,6 cyclohepta 1,2-b pyridine
Desloratadine related compound F
8-Chloro-6,11-dihydro-11-(N-formyl-4-piperidinylidene)-5H-benzo 5,6 cyclohepta 1,2-b pyridine
5-chloro-2-methylaminobenzophenone
5-chloro-2-methylaminobenzophenone
3-amino-6-chloro-1-methyl-4-phenylquinolin-2-ol
3-amino-6-chloro-1-methyl-4-phenylquinolin-2-ol
Eribulin impurity C
(2R,3R,3aS,7R,8aS,9S,10aR,11S,12R,13aR,13bS,15S,18S, 21S,24S,26R,28R,29aS)-2- (2R)-2-Amino-3-hydroxypropyl -3-methoxy-26-methyl-20,27-dimethylidenehexacosahydro-11,15 18,21 24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo 3,2-i furo 2,3 5,6 pyrano 4,3-b 1,4 dioxacyclopentacosin-5(4H)-one
Etravirine system suitability mixture
Etravirine amino analog(4- (4-Amino-5-bromo-6-chloropyrimidin-2-yl)amino benzonitrile..)
Etravirine system suitability mixture
Desbromoetravirine (4-(6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl oxy)-3,5-dimethylbenzonitrile.)
Frusemide related compound B
(2-amino-4-chloro-5 sulphamoylbenzoic acid),
Fulvestrant Impurity A
7- 9- (RS)-4,4,5,5,5-pentafl uoropentane-1-sulfinyl nonyl estra-1,3,5(10) triene-3,17-diol (7-fulvestrant),
Galantamine hydrobromide related compound mixture
galantamine N oxide
Galantamine hydrobromide related compound mixture
dihydrogalantamine
Iohexol related compound B
(5-amino-N, N-bis (2,3-dihydroxy propyl)-2,4.6-triiodo-1,3-benzenedicarbonamide)
Iohexol related compound A
(5-(Acetylamino)-N,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3 benzenedicarboxamide)
Iohexol related compound C
N,N-Bis(2,3-dihydroxypropyl)-5-nitro-1,3- benzenedicarboxamide
Micafuin epimer
Sodium 5- (1S,2S)-2-(2R,6S,9S,11R,12S,14aS,15S,16S,20S,23S,25aS)-20- (R)-3-amino-1-hydroxy-3-oxopropyl -2,11,12,15-tetrahydroxy-6- (R)-1- hydroxyethyl -16-methyl-5,8,14,19,22,25-hexaoxo-9-(4-(5- 4-(pentyloxy)phenyl isoxazol-3-yl)benzamido)tetracosahydro-1H-dipyrrolo 2,1-c 2,1- l 1,4,7,10,13,16 hexaazacyclohenicosin-23-yl)-1,2-dihydroxyethyl -2-hydroxyphenyl sulfate,
Minocycline impurity A
(4R,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11 dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide(4 epiminocycline),
Minocycline impurity B
(4S,4aS,5aR,12aS)-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11 dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide (sancycline),
Minocycline impurity C
(4S,4aS,5aR,12aS)-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-7 (methylamino)-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2 carboxamide(7-monodemethylminocycline),
Minocycline impurity E
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12a-trihydroxy-12-imino 1,11-dioxo-1,4,4a,5,5a,6,11,11a,12,12a-decahydrotetracene-2-carboxamide.
Minocycline impurity F
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-N (hydroxymethyl)-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2 carboxamide,
Minocycline impurity G
(4S,4aS,5aR,12aS)-4,7,9-tris(dimethylamino)-3,10,12,12a-tetrahydroxy 1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide,
Minocycline impurity H
(4S,4aS,12aS)-4,7-bis(dimethylamino)-3,10,11,12a-tetrahydroxy-1,12 dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide,
Morphine impurity F
(17S)-4,5a-epoxy-3,6a-dihydroxy-17-methyl-7,8-didehydromorphinan 17-oxide (morphine N-oxide).
Pilocarpine impurity A
( (3R,4R)-3-ethyl-4- (1-methyl-1H-imidazol-5-yl)methyl dihydrofuran-2(3H)-one. (isopilocarpine) )
3-amino-4-propoxybenzoic acid
3-amino-4-propoxybenzoic acid
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Acamprosate Gastro-resistant Tablets | Acamprosate calcium | 100 | gram | ipcpvpi_gaurav | 60 | |
| 2 | Adapalene | Adapalene | 100 | gram | ipcpvpi_gaurav | 60 | |
| 3 | Adenine | Adenine | 100 | gram | ipcpvpi_gaurav | 60 | |
| 4 | Bedaquiline fumarate | Bedaquiline fumarate | 100 | gram | ipcpvpi_gaurav | 60 | |
| 5 | Bepotastine besilate | Bepotastine besilate | 100 | gram | ipcpvpi_gaurav | 60 | |
| 6 | Calcium Folinate Tablets | Calcium folinate | 100 | gram | ipcpvpi_gaurav | 60 | |
| 7 | Calcium Polystyrene Sulphonate | Calcium polystyrene sulphonate | 100 | gram | ipcpvpi_gaurav | 60 | |
| 8 | Cefprozil | Cefprozil Z isomer | 100 | gram | ipcpvpi_gaurav | 60 | |
| 9 | Cefprozil | Cefprozil E isomer | 100 | gram | ipcpvpi_gaurav | 60 | |
| 10 | Dactinomycin or Dactinomycin for Injection | Dactinomycin | 100 | gram | ipcpvpi_gaurav | 60 | |
| 11 | Dapagliflozin or Dapagliflozin and Metformin Hydrochloride Prolonged-release Tablets | Dapagliflozin | 100 | gram | ipcpvpi_gaurav | 60 | |
| 12 | Dapagliflozin Propanediol Monohydrate | Dapagliflozin propanediol monohydrate | 100 | gram | ipcpvpi_gaurav | 60 | |
| 13 | Desloratadine or Desloratadine Tablets | Desloratadine | 100 | gram | ipcpvpi_gaurav | 60 | |
| 14 | Entecavir Oral Solution | Entecavir monohydrate | 100 | gram | ipcpvpi_gaurav | 60 | |
| 15 | Eribulin Mesylate | Methanesulphonic acid | 100 | gram | ipcpvpi_gaurav | 60 | |
| 16 | Eribulin Mesylate or Eribulin Injection | Eribulin mesilate | 100 | gram | ipcpvpi_gaurav | 60 | |
| 17 | Etravirine or Etravirine Tablets | Etravirine | 100 | gram | ipcpvpi_gaurav | 60 | |
| 18 | Fulvestrant Injection | Fulvestrant | 100 | gram | ipcpvpi_gaurav | 60 | |
| 19 | Low-Substituted Hydroxypropyl Cellulose | Low- substituted hydroxypropyl cellulose | 100 | gram | ipcpvpi_gaurav | 60 | |
| 20 | Iohexol or Iohexol Injection | Iohexol | 100 | gram | ipcpvpi_gaurav | 60 | |
| 21 | Micafungin Sodium | Micafungin sodium | 100 | gram | ipcpvpi_gaurav | 60 | |
| 22 | Minocycline Hydrochloride or cap or Inj or Tab | Minocycline hydrochloride | 100 | gram | ipcpvpi_gaurav | 60 | |
| 23 | Morphine Prolonged-release Tablets | Morphine sulphate | 100 | gram | ipcpvpi_gaurav | 60 | |
| 24 | Morphine Prolonged-release Tablets | Codeine phosphate | 100 | gram | ipcpvpi_gaurav | 60 | |
| 25 | Oxytocin Concentrated Solution | Oxytocin | 100 | gram | ipcpvpi_gaurav | 60 | |
| 26 | Oxytocin Concentrated Solution | Desmopressin | 100 | gram | ipcpvpi_gaurav | 60 | |
| 27 | Phytomenadione Tablets | Phytomenadione | 100 | gram | ipcpvpi_gaurav | 60 | |
| 28 | Pilocarpine Hydrochloride or Pilocarpine Hydrochloride Eye drops | Pilocarpine hydrochloride | 100 | gram | ipcpvpi_gaurav | 60 | |
| 29 | Pilocarpine Hydrochloride Eye drops | Pilocarpine nitrate | 100 | gram | ipcpvpi_gaurav | 60 | |
| 30 | Pomalidomide or Cap | Pomalidomide | 100 | gram | ipcpvpi_gaurav | 60 | |
| 31 | Proparacaine Hydrochloride or Proparacaine Eye Drops | Proparacaine hydrochloride | 100 | gram | ipcpvpi_gaurav | 60 | |
| 32 | Acamprosate impurity A | 3-Amino-1-propanesulphonic acid | 10 | gram | ipcpvpi_gaurav | 60 | |
| 33 | Acetylcysteine impurity A | 3, 3-disulphanediylbis (2R)-2-aminopropanoic acid (L-cystine) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 34 | Acetylcysteine impurity B | 2(2R)-2-amino-3-sulphanylpropanoic acid (L-cysteine) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 35 | Acetylcysteine impurity C | 33,3-disulphanediylbis(2R)-2-acetamidopropanoic acid (N, N-diacetyl-L cystine) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 36 | Acetylcysteine impurity D | (2R)-2-acetamido-3-(acetylsulphanyl)propanoic acid (N,S-diacetyl-L cysteine) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 37 | Adapalene impurity C | (1-(2-methoxyphenyl)tricyclo 3.3.1.13,7 decane) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 38 | Adapalene impurity A | (2,2-binaphthalene-6,6-dicarboxylic acid) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 39 | Adapalene impurity D | (1,1-4,4-bis(methoxy)biphenyl-3,3 Diyl bis (tricyclo 3.3.1.13,7 decane)) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 40 | Bedaquiline impurity B | (1S,2R)-1-(6-bromo-2-methoxy-3quinolinyl)-4-(dimethylamino)-2-(3benzo b thiophenyl)-1-pheny-2-butanol. | 10 | gram | ipcpvpi_gaurav | 60 | |
| 41 | Bepotastine besilate R-isomer impurity | (R)-4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid--benzenesulfonic acid | 10 | gram | ipcpvpi_gaurav | 60 | |
| 42 | Bepotastine impurity A | ((S)-4-((4-chlorophenyl)-2 (pyredylmethoxy piperidine) in the solvent mixture | 10 | gram | ipcpvpi_gaurav | 60 | |
| 43 | Amoxycillin related compound I | (R)-2-Amino-2-(4-hydroxyphenyl) acetic acid | 10 | gram | ipcpvpi_gaurav | 60 | |
| 44 | Cefprozil related compound D | (6R,7R)-7-Amino-8- oxo-3-(Z)-prop-1-enyl-5-thia-1-azabicyclo 4.2.0 oct-2-ene-2-carboxylic acid, | 10 | gram | ipcpvpi_gaurav | 60 | |
| 45 | Celecoxib impurity A | (4- 5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl benzenesulphonamide) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 46 | Celecoxib impurity B | (4- 3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl benzenesulphonamide) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 47 | Clarithromycin identity | clarithromycin + clarithromycin impurity D (3-N-demethyl-6-O-methylerythromycin A) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 48 | Clindamycin impurity E | (methyl 7-chloro-6,7,8-trideoxy-6- (2S,4R)-1-methyl-4-propylpyrrolidin 2-yl carbonyl amino -1-thio-L-threo-D-galacto-octopyranoside (clindamycin). | 10 | gram | ipcpvpi_gaurav | 60 | |
| 49 | Clindamycin impurity F | (methyl 6,8-dideoxy 6- (2S,4R)-1-methyl-4-propylpyrrolidin-2-yl carbonyl amino -2-O-phosphono-1-thio-D-erythro-D-galacto octopyranoside (lincomycin 2-phosphate)) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 50 | Clindamycin impurity G | (methyl 6,8-dideoxy-2,4-O-(hydroxyphosphoryl)-6- (2S,4R)-1-methyl-4 propylpyrrolidin-2-yl carbonyl amino -1-thio-D-erythro-D-galacto octopyranoside (2,4-phosphatidyl lincomycin)) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 51 | Clindamycin impurity I | methyl 7-chloro-6,7,8-trideoxy-6- (2S,4R)-1-methyl-propylpyrrolidin 2-yl carbonyl amino -2,4-di-O-phosphono-1-thio-L-threo--D-galacto octopyranoside (clindamycin 2,4-bisphosphate)) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 52 | Clindamycin impurity J | (methyl 7-chloro-6,7,8-trideoxy-6- (2S)-1-methyl-4 propylidenepyrrolidin-2-yl carbonyl amino -2-O-phosphono-1-thio-L threo--D-galacto-octopyranoside (propylidene analog of clindamycin 2-phosphate)) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 53 | Clindamycin impurity K | 2,2-oxybis(hydroxyphosphoryl)bis methyl 7-chloro-6,7,8-trideoxy-6- (2S,4R)-1-methyl-4-propylpyrrolidin-2-yl carbonyl amino -1-thio-L- threo--D-galacto-octopyranoside (diclindamycin pyrophosphate). | 10 | gram | ipcpvpi_gaurav | 60 | |
| 54 | Clindamycin impurity B | methyl 7-chloro-6,7,8-trideoxy-6- (2S,4R)-4-ethyl-1-methylpyrrolidin-2-yl carbonyl amino -2-O-phosphono-1-thio-L-threo--D-galacto- octopyranoside (clindamycin B 2-phosphate). | 10 | gram | ipcpvpi_gaurav | 60 | |
| 55 | Clindamycin impurity L | (methyl 7-chloro-6,7,8-trideoxy-6- (2S,4R)-1-methyl-propylpyrrolidin 2-yl carbonyl amino -2-O-phosphono-1-thio-D-erythro--D-galacto octopyranoside (7-epiclindamycin 2-phosphate) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 56 | Ortho isomer of dapagliflozin impurity | (1S)-1,5-anhydro-1-C-(4-chloro-3- (2-ethoxyphenyl)methyl phenyl)-D-glucitol | 10 | gram | ipcpvpi_gaurav | 60 | |
| 57 | Dapagliflozin dimer-1 | (2S,3R,4R,5S,6R)-2- 4-chloro-3- (5-(2-Chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl benzyl -2-ethoxyphenyl)(4-ethoxyphenyl)methyl phenyl -6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | 10 | gram | ipcpvpi_gaurav | 60 | |
| 58 | Dapagliflozin impurity A | ((1S)-1,5-anhydro-1 4-bromo-3- (4-ethoxyphenyl)methyl phenyl -D glucitol) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 59 | Dapagliflozin impurity B | ((1S)-1,5-anhydro-1 4-chloro-3- (4-ethoxy-3-ethylphenyl) methyl phenyl D-glucitol.) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 60 | Desloratadine related compound B | 8-Chloro-11-(1,2,3,6-tetrahydropyridin-4-yl)-6,11-dihydro-5H-benzo 5,6 cyclohepta 1,2-b pyridine hydrochloride. | 10 | gram | ipcpvpi_gaurav | 60 | |
| 61 | Desloratadine related compound A | 8-Bromo-6,11-dihydro-11-(piperidin-4-ylidene)-5H-benzo 5,6 cyclohepta 1,2-b pyridine | 10 | gram | ipcpvpi_gaurav | 60 | |
| 62 | Desloratadine related compound F | 8-Chloro-6,11-dihydro-11-(N-formyl-4-piperidinylidene)-5H-benzo 5,6 cyclohepta 1,2-b pyridine | 10 | gram | ipcpvpi_gaurav | 60 | |
| 63 | 5-chloro-2-methylaminobenzophenone | 5-chloro-2-methylaminobenzophenone | 10 | gram | ipcpvpi_gaurav | 60 | |
| 64 | 3-amino-6-chloro-1-methyl-4-phenylquinolin-2-ol | 3-amino-6-chloro-1-methyl-4-phenylquinolin-2-ol | 10 | gram | ipcpvpi_gaurav | 60 | |
| 65 | Eribulin impurity C | (2R,3R,3aS,7R,8aS,9S,10aR,11S,12R,13aR,13bS,15S,18S, 21S,24S,26R,28R,29aS)-2- (2R)-2-Amino-3-hydroxypropyl -3-methoxy-26-methyl-20,27-dimethylidenehexacosahydro-11,15 18,21 24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo 3,2-i furo 2,3 5,6 pyrano 4,3-b 1,4 dioxacyclopentacosin-5(4H)-one | 10 | gram | ipcpvpi_gaurav | 60 | |
| 66 | Etravirine system suitability mixture | Etravirine amino analog(4- (4-Amino-5-bromo-6-chloropyrimidin-2-yl)amino benzonitrile..) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 67 | Etravirine system suitability mixture | Desbromoetravirine (4-(6-Amino-2-((4-cyanophenyl)amino)pyrimidin-4-yl oxy)-3,5-dimethylbenzonitrile.) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 68 | Frusemide related compound B | (2-amino-4-chloro-5 sulphamoylbenzoic acid), | 10 | gram | ipcpvpi_gaurav | 60 | |
| 69 | Fulvestrant Impurity A | 7- 9- (RS)-4,4,5,5,5-pentafl uoropentane-1-sulfinyl nonyl estra-1,3,5(10) triene-3,17-diol (7-fulvestrant), | 10 | gram | ipcpvpi_gaurav | 60 | |
| 70 | Galantamine hydrobromide related compound mixture | galantamine N oxide | 10 | gram | ipcpvpi_gaurav | 60 | |
| 71 | Galantamine hydrobromide related compound mixture | dihydrogalantamine | 10 | gram | ipcpvpi_gaurav | 60 | |
| 72 | Iohexol related compound B | (5-amino-N, N-bis (2,3-dihydroxy propyl)-2,4.6-triiodo-1,3-benzenedicarbonamide) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 73 | Iohexol related compound A | (5-(Acetylamino)-N,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3 benzenedicarboxamide) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 74 | Iohexol related compound C | N,N-Bis(2,3-dihydroxypropyl)-5-nitro-1,3- benzenedicarboxamide | 10 | gram | ipcpvpi_gaurav | 60 | |
| 75 | Micafuin epimer | Sodium 5- (1S,2S)-2-(2R,6S,9S,11R,12S,14aS,15S,16S,20S,23S,25aS)-20- (R)-3-amino-1-hydroxy-3-oxopropyl -2,11,12,15-tetrahydroxy-6- (R)-1- hydroxyethyl -16-methyl-5,8,14,19,22,25-hexaoxo-9-(4-(5- 4-(pentyloxy)phenyl isoxazol-3-yl)benzamido)tetracosahydro-1H-dipyrrolo 2,1-c 2,1- l 1,4,7,10,13,16 hexaazacyclohenicosin-23-yl)-1,2-dihydroxyethyl -2-hydroxyphenyl sulfate, | 10 | gram | ipcpvpi_gaurav | 60 | |
| 76 | Minocycline impurity A | (4R,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11 dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide(4 epiminocycline), | 10 | gram | ipcpvpi_gaurav | 60 | |
| 77 | Minocycline impurity B | (4S,4aS,5aR,12aS)-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11 dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide (sancycline), | 10 | gram | ipcpvpi_gaurav | 60 | |
| 78 | Minocycline impurity C | (4S,4aS,5aR,12aS)-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-7 (methylamino)-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2 carboxamide(7-monodemethylminocycline), | 10 | gram | ipcpvpi_gaurav | 60 | |
| 79 | Minocycline impurity E | (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12a-trihydroxy-12-imino 1,11-dioxo-1,4,4a,5,5a,6,11,11a,12,12a-decahydrotetracene-2-carboxamide. | 10 | gram | ipcpvpi_gaurav | 60 | |
| 80 | Minocycline impurity F | (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-N (hydroxymethyl)-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2 carboxamide, | 10 | gram | ipcpvpi_gaurav | 60 | |
| 81 | Minocycline impurity G | (4S,4aS,5aR,12aS)-4,7,9-tris(dimethylamino)-3,10,12,12a-tetrahydroxy 1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, | 10 | gram | ipcpvpi_gaurav | 60 | |
| 82 | Minocycline impurity H | (4S,4aS,12aS)-4,7-bis(dimethylamino)-3,10,11,12a-tetrahydroxy-1,12 dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide, | 10 | gram | ipcpvpi_gaurav | 60 | |
| 83 | Morphine impurity F | (17S)-4,5a-epoxy-3,6a-dihydroxy-17-methyl-7,8-didehydromorphinan 17-oxide (morphine N-oxide). | 10 | gram | ipcpvpi_gaurav | 60 | |
| 84 | Pilocarpine impurity A | ( (3R,4R)-3-ethyl-4- (1-methyl-1H-imidazol-5-yl)methyl dihydrofuran-2(3H)-one. (isopilocarpine) ) | 10 | gram | ipcpvpi_gaurav | 60 | |
| 85 | 3-amino-4-propoxybenzoic acid | 3-amino-4-propoxybenzoic acid | 10 | gram | ipcpvpi_gaurav | 60 |
Corrigendum Updates
1 Update Update
Extended Deadline
04-Sep-2025, 6:30 am
Opening Date
04-Sep-2025, 7:00 am
Required Documents
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer